Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Pathology|March 1, 2021
Machine learning and augmented human intelligence use in histomorphology for haematolymphoid disordersAhmad Nanaa, Zeynettin Akkus, Winston Y Lee, et al.Journal of Clinical Medicine|June 2, 2021
Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic HematopathologyMazen Osman, Zeynettin Akkus, Dragan Jevremovic, et al.British Journal of Haematology|September 15, 2023
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patientsAhmad Nanaa, Rong He, James M Foran, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|October 28, 2022
Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysisSahrish Shah, Meritxell Urtecho, Mohammed Firwana, et al.Blood Cancer Journal|September 22, 2023
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneityTalha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, et al.Chest|December 3, 2022
Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants: A Systematic Review and Meta-analysisSahrish Shah, Tarek Nayfeh, Bashar Hasan, et al.Blood Cancer Journal|July 8, 2022
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasmsMithun Vinod Shah, Abhishek A Mangaonkar, Kebede H Begna, et al.Blood Advances|October 13, 2021
Genetic features and clinical outcomes of patients with isolated and comutated DDX41-mutated myeloid neoplasmsHassan B Alkhateeb, Ahmad Nanaa, David Viswanatha, et al.Haematologica|May 18, 2023
Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasmsTalha Badar, Ahmad Nanaa, James M Foran, et al.Haematologica|May 30, 2024
Prognostic impact of 'multi-hit' versus 'single-hit' TP53 alteration in patients with acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic DiseasesTalha Badar, Ahmad Nanaa, Ehab Atallah, et al.Pageof 2